Chiral Bisoxazoline Ligands Enable Nickel-Catalyzed Enantioselective C(sp³)–O Bond Construction via Dynamic Kinetic Control

Created on 01.09

I. Research Background and Significance

Chiral ethers are key structural motifs in bioactive molecules, but enantioselective C(sp³)–O bond formation​ from racemic alkyl electrophiles remains a persistent challenge. Conventional methods rely on enantiopure substrates, facing limitations in substrate accessibility, harsh reaction conditions, and structural diversity. Existing metal-catalyzed enantioconvergent C–O coupling strategies are largely restricted to π-activated electrophiles.
The team of Prof. Yuli He and Hequan Yao​ at China Pharmaceutical University developed a nickel-catalyzed enantioconvergent reaction​ using chiral bisoxazoline ligands, achieving dynamic kinetic resolution (DKR) via halide-driven substrate racemization. This method enables the coupling of racemic secondary alkyl halides with hydroxamic acids under mild, air- and moisture-tolerant conditions, providing efficient access to enantiomerically enriched O-alkylhydroxamates.

II. Reaction Design and Breakthrough

Published in: Journal of the American Chemical Society (JACS)
Authors: Jinze Du, Xiaoying Fu, Siming Xie, Yue Wang, Hequan Yao, Yuli He
Key Innovations:
  • Dynamic Kinetic Control: Halide-induced in situ racemization enables complete substrate conversion without external racemization catalysts.
  • Mild Conditions: Reactions proceed efficiently under ambient atmosphere, eliminating the need for strict anhydrous/anaerobic operations.
  • High Stereoselectivity: Enantiomeric excess (ee) consistently exceeds 93%, surpassing conventional approaches.
Standard Reaction Conditions:
  • Catalyst: Ni(OTf)₂ (5–10 mol%)
  • Ligand: Chiral bisoxazoline (6–12 mol%)
  • Substrates: Racemic secondary alkyl bromide (1.0 equiv) + hydroxamic acid (1.2–3.0 equiv)
  • Base: K₃PO₄ (2.0 equiv)
  • Solvent: DMSO/THF mixture, room temperature
  • Yields and ee values determined by ¹H NMR and chiral HPLC, respectively

III. Advantages of Chiral Bisoxazoline Ligands

  1. Precise Stereocontrol​ The rigid chiral pocket formed by Ni–bisoxazoline complexes governs the stereochemistry of S_N2 transition states, achieving >93% ee​ consistently.
  2. Broad Substrate Scope​ Hydroxamic Acids: Aromatic, aliphatic, and heterocyclic variants are well-tolerated. Alkyl Halides: Compatible with esters, thioethers, halogenated arenes, trifluoromethyl groups, and sterically hindered propargyl/cycloalkyl substrates.
  3. Excellent Stability and Practicality​ The catalytic system operates efficiently under ambient conditions, enhancing reproducibility and operational simplicity.
  4. Synergistic Dynamic Kinetic Resolution​ Ligand design synergizes with halide-driven racemization, enabling complete substrate conversion without additional reagents.

IV. Applications in Drug Synthesis

The methodology was applied to concise syntheses of pharmacologically relevant molecules:
  1. Rho Pathway Inhibitor (S)-CCG-1423: Synthesized in only 3 steps​ from commercial materials.
  2. γ-Secretase Inhibitor LY411575: Efficient access to its chiral ether intermediate with high enantioselectivity.

V. Technical Support and Ligand Availability

To support further research, Anhui Kaitai Laibo​ offers a series of chiral bisoxazoline ligands and custom synthesis services.

VI. Publication Details

Journal: Journal of the American Chemical Society
DOI: 10.1021/jacs.5c18000
Highlight: First nickel-catalyzed enantioconvergent C(sp³)–O coupling via dynamic kinetic control, providing a robust platform for chiral ether synthesis.

Join Our Community

We are trusted by over 2000+ clients. Join them and grow your business.

Contact Us